Susquehanna International Group, LLP Anixa Biosciences Inc Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 07, 2024
SELL
$3.08 - $5.02 $40,964 - $66,766
-13,300 Reduced 39.7%
20,200 $63,000
Q4 2023

Feb 14, 2024
BUY
$2.85 - $4.19 $95,475 - $140,365
33,500 New
33,500 $129,000
Q3 2022

Nov 14, 2022
BUY
$2.81 - $6.15 $281 - $615
100 Added 0.78%
13,000 $64,000

Others Institutions Holding ANIX

# of Institutions
60
Shares Held
5.56M
Call Options Held
21K
Put Options Held
6.7K
View Full List

About Anixa Biosciences Inc

ANIX Quotes by TradingView
  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $84M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email